| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/15/2011 | US20110224269 Analgesic Compounds, Compositions, and Uses Thereof |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224266 4 aminopyridine and a pharmaceutical composition for treatment of neuronal disorders |
| 09/15/2011 | US20110224263 Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 09/15/2011 | US20110224261 Crystalline form of 4-(5--4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
| 09/15/2011 | US20110224259 Novel inhibitors |
| 09/15/2011 | US20110224256 Therapeutic imprinting for the treatment of psychiatric disorders |
| 09/15/2011 | US20110224255 Tripeptidyl peptidase inhibitors |
| 09/15/2011 | US20110224254 Novel inhibitors |
| 09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 09/15/2011 | US20110224247 Azaisoquinolinone derivatives as nk3 antagonists |
| 09/15/2011 | US20110224245 Treatment Of Neurological Disorders Using Huperzine |
| 09/15/2011 | US20110224234 Polymorph B of N--N-methyl-acetamide |
| 09/15/2011 | US20110224231 Novel Lactams as Beta Secretase Inhibitors |
| 09/15/2011 | US20110224230 Bicyclic dihydroimidazolone cgrp receptor antagonists |
| 09/15/2011 | US20110224225 Inhibitors of protein kinases |
| 09/15/2011 | US20110224220 Substituted tricyclic derivatives |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224204 Di-substituted phenyl compounds |
| 09/15/2011 | US20110224202 Pde10 inhibitors and related compositions and methods |
| 09/15/2011 | US20110224201 Cgrp receptor antagonists |
| 09/15/2011 | US20110224200 Therapeutic agent for chorioretinal degenerative disease containing pyridine-3-carbaldehyde 0-(piperidin-1-yl-propyl)-oxime derivative as active ingredient |
| 09/15/2011 | US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 09/15/2011 | US20110224198 Aryl methyl benzoquinazolinine m1 receptor positive allosteric modulators |
| 09/15/2011 | US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 09/15/2011 | US20110224196 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| 09/15/2011 | US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 09/15/2011 | US20110224184 Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis |
| 09/15/2011 | US20110224181 Methods for the treatment of a traumatic central nervous system injury |
| 09/15/2011 | US20110224180 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224171 Inhibitors of fatty acid amide hydrolase |
| 09/15/2011 | US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) |
| 09/15/2011 | US20110224162 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity of the inflammatory response |
| 09/15/2011 | US20110224156 Propionic Acids, Propionic Acid Esters, and Related Compounds |
| 09/15/2011 | US20110224147 Methods and compositions |
| 09/15/2011 | US20110224146 Augmented cognitive training |
| 09/15/2011 | US20110224145 Neuromodulators and Methods of Use |
| 09/15/2011 | US20110224144 Compositions and methods for diagnosing and treating mental disorders |
| 09/15/2011 | US20110224140 Human chorionic gonadotropin (hcg) orally or for injection for the treatment of mood disorders and alcoholism |
| 09/15/2011 | US20110224133 Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases |
| 09/15/2011 | US20110224132 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223249 Extended release compositions comprising mycophenolate sodium and processes thereof |
| 09/15/2011 | US20110223247 Pharmaceutical compositions for release control of methylphenidate |
| 09/15/2011 | US20110223246 Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source |
| 09/15/2011 | US20110223245 Controlled-release formulations of pramipexole |
| 09/15/2011 | US20110223240 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them |
| 09/15/2011 | US20110223237 Selegiline-containing adhesive preparation |
| 09/15/2011 | US20110223236 Selegiline-containing adhesive preparation |
| 09/15/2011 | US20110223235 Selegiline-containing adhesive preparation |
| 09/15/2011 | US20110223233 Microfabricated nanopore device for sustained release of therapeutic agent |
| 09/15/2011 | US20110223207 Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same |
| 09/15/2011 | US20110223205 Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
| 09/15/2011 | US20110223175 Gene Encoding G-Protein Coupled Receptor And Gene Product Thereof |
| 09/15/2011 | US20110223150 Neutraceutical-Based Topical Anxiolytic Agent and Method of Use |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110220265 Preparation for External Use |
| 09/15/2011 | DE102010011069A1 Method for targeted pharmacological and co-psychotherapeutic treatment of alcohol dependence with baclofen and nalmefene |
| 09/15/2011 | DE102010010998A1 Feste pharmazeutische Zusammensetzung, umfassend Donepezil-Hydrochlorid der kristallinen polymorphen Form I Solid pharmaceutical composition comprising donepezil hydrochloride of crystalline polymorph Form I |
| 09/15/2011 | CA2792844A1 Pde10 inhibitors and related compositions and methods |
| 09/15/2011 | CA2792598A1 Propionic acids, propionic acid esters, and related compounds |
| 09/15/2011 | CA2792539A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 09/15/2011 | CA2792520A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 09/15/2011 | CA2792503A1 Analgesic compounds, compositions, and uses thereof |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2792157A1 Arylvinylazacycloalkane compounds for constipation |
| 09/15/2011 | CA2792112A1 Maternal sialic acid supplementation |
| 09/15/2011 | CA2791460A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
| 09/15/2011 | CA2790571A1 Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases |
| 09/15/2011 | CA2789440A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | CA2789189A1 Inhibitors of protein kinases |
| 09/14/2011 | EP2365071A1 Transformed soybean plant which stores vaccine, and use thereof |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364983A2 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364975A1 Novel amide derivative and use thereof as medicine |
| 09/14/2011 | EP2364967A2 Process for preparation of rasagiline and salts thereof |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364728A1 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 09/14/2011 | EP2364727A2 Molecular antigen array |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364710A1 Therapeutic use of D-allose |
| 09/14/2011 | EP2364708A2 Pharmaceutical composition comprising a C1C-2 channel opener |
| 09/14/2011 | EP2364706A1 Pharmaceutical agent comprising quinolone compound |
| 09/14/2011 | EP2364705A2 Modulators of muscarinic receptors |
| 09/14/2011 | EP2364701A1 Omega-3 fatty acid formulations |
| 09/14/2011 | EP2364317A2 Dopamine receptor ligands with enhanced duration of action |
| 09/14/2011 | EP2364316A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d¨pyrimidin-4-yl]-quinolin-3 -ylamine compounds useful as FAAH modulators and uses thereof |
| 09/14/2011 | EP2364311A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1 |
| 09/14/2011 | EP2364308A1 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 09/14/2011 | EP2364307A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine |
| 09/14/2011 | EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 09/14/2011 | EP2364303A1 Aryl piperazine and their use as alpha2c antagonists |
| 09/14/2011 | EP2364168A1 Extended length botulinum toxin formulation for human or mammalian use |
| 09/14/2011 | EP2364157A1 Plant extract compositions for affecting sleep |
| 09/14/2011 | EP2364151A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |